18 F-Fallypride and 11 C-FLB457 are commonly used PET radioligands for imaging extrastriatal dopamine D 2 /D 3 receptors, but differences in their in vivo kinetics may affect the sensitivity for measuring subtle changes in receptor binding. Focusing on regions of low binding, a direct comparison of the kinetics of 18 F-fallypride and 11 C-FLB457 was made using a MI protocol. Injection protocols were designed to estimate K 1 , k 2 , f ND k on , B max , and k off in the midbrain and cortical regions of the rhesus monkey. 11 C-FLB457 cleared from the arterial plasma faster and yielded a ND space distribution volume (K 1 /k 2 ) that is three times higher than 18 F-fallypride, primarily due to a slower k 2 (FAL:FLB; k 2 = 0.54 min À1 :0.18 min À1 ). The dissociation rate constant, k off , was slower for 11 C-FLB457, resulting in a lower K Dapp than 18 F-fallypride (FAL:FLB; 0.39 nM:0.13 nM). Specific D 2 /D 3 binding could be detected in the cerebellum for 11 C-FLB457 but not 18 F-fallypride. Both radioligands can be used to image extrastriatal D 2 /D 3 receptors, with 11 C-FLB457 providing greater sensitivity to subtle changes in low-receptor-density cortical regions and 18 F-fallypride being more sensitive to endogenous dopamine displacement in medium-to-high-receptor-density regions. In the presence of specific D 2 /D 3 binding in the cerebellum, reference region analysis methods will give a greater bias in BP ND with 11 C-FLB457 than with 18 F-fallypride.
Introduction
Extrastriatal dopamine D 2 /D 3 receptors have a functional role in normal cognitive processing, motivation regulation, and reward processing; and disruption of their circuitry may be implicated in the etiology of several neuropsychiatric disorders. The positron emission tomography (PET) radioligands 18 F-fallypride and 11 C-FLB457, both high-affinity D 2 /D 3 antagonists, provide the ability to image receptors in low concentrations ( < 1 nmol/L) and serve as valuable biomarkers for studying the dopaminergic system. For high-affinity radiotracers, longer scan times ( > 2 h) are required for accurate assay in high-density regions, thus limiting the utility of 11 C-FLB457 for striatal D 2 /D 3 measurement (Olsson and Farde, 2001) . A number of studies have been conducted to characterize the in vivo kinetics of these radiotracers and to evaluate experimental designs for measuring extrastriatal D 2 /D 3 receptor binding. Of particular interest is the determination of the sensitivity of these radioligands to variations in endogenous dopamine concentrations (Mukherjee et al, 2005; Narendran et al, 2009; Okauchi et al, 2001; Riccardi et al, 2008; Slifstein et al, 2004b) , determination of in vivo affinity Mukherjee et al, 1999; Olsson et al, 2004; Slifstein et al, 2004a) , as well as the testing the validity of the cerebellum as a reference region (Asselin et al, 2007; Christian et al, 2004; Delforge et al, 1999; Olsson et al, 1999; Olsson et al, 2004) .
For assessment of endogenous dopamine competition, it has been suggested that the radiotracer vascular transport rate constants, K 1 and k 2 , have a significant effect on the sensitivity for detecting endogenous dopamine release (Morris and Yoder, 2006) , despite these rate constants not being directly related to receptor binding. In a challenge-type experiment (i.e., amphetamine challenge), competitive dopamine release is evoked after administration of radioligand; it was simulated that 11 C-raclopride yielded the highest sensitivity for detecting dopamine release in the striatum, as compared with other radiotracers, including 18 F-fallypride, 11 C-FLB457, and several other frequently used radioligands. The increased detection sensitivity was not attributed to the rate constants involved in specific binding of the radioligand to the receptor site, but rather to the tissue-to-plasma efflux rate constant, k 2 . A fast k 2 constant provides rapid clearance of the radioligand from the free space after displacement by endogenous neurotransmitter, thus enhancing the change in the PET signal, which represents both bound and free states. However, in the case of extrastriatal D 2 /D 3 receptor binding, 11 C-raclopride does not have sufficient target-to-background signal to detect subtle changes in the specific binding. In these regions, higher-affinity radiotracers are required to provide a suitable signal from the specifically bound component of the PET measurement.
High affinity by itself is not sufficient for extrastriatal assay; a radiotracer must also have low nonspecific uptake, which is dependent on lipophilicity and nonspecific protein binding. This issue was illustrated by a semi-quantitative in vivo comparison of 11 C-fallypride, 11 C-FLB457 with 11 C-cyclopropyl-FLB457 (Airaksinen et al, 2006) . 11 C-cyclopropyl-FLB457 has been investigated as a candidate radioligand for extrastriatal D 2 /D 3 binding due to its high in vitro D 2 /D 3 affinity, which is 10-fold greater than that of fallypride and FLB457 (Airaksinen et al, 2008) . Semi-quantitative comparisons of these radiotracers showed similar target/ cerebellum ratios in the subcortical and cortical regions, despite the significantly higher affinity of 11 C-cyclopropyl-FLB457 for the D 2 /D 3 receptors.
Designing and conducting PET experiments to separate and uniquely identify the radioligand delivery and binding components is challenging for a single bolus injection PET study. Frequently there is high covariance between the parameter estimates of delivery (K 1 , k 2 ) and binding (k 3 , k 4 ), particularly for high-affinity radiotracers with rapid specific binding (k 3 ). This high covariance limits the interpretation of each parameter independently. To effectively uncouple the in vivo parameters for the characterization of 18 F-fallypride and 11 C-FLB457, it is necessary to introduce several injections of ligand, each time varying the concentrations of unlabeled and radiolabeled ligand. These multiple-injection (MI) PET experiments methodologically perturb and observe the system to separate the high covariance between parameters by introducing competition between the labeled and unlabeled ligand for the receptor site .
MI PET strategies have been used for both FLB457 and fallypride to provide in vivo estimation of radioligand-receptor characteristics. Using the long-lived 76 Br (t 1/2 = 16.1 h) radiolabel, FLB457 has been evaluated in baboons for estimation of receptor density (B max ) (Delforge et al, 1999) and for assay of endogenous dopamine competition (Delforge et al, 2001) . For 18 F-fallypride, MI studies have been reported using rhesus monkeys for in vivo characterization and using baboons for measurement of in vivo affinity (Slifstein et al, 2004a) . It must be stressed that MI studies are uniquely designed to optimize the estimation of a particular parameter of interest. For example, an MI design occurring over several separate imaging sessions can yield estimates of the apparent affinity (through scatchard type of analysis) (Holden et al, 2002) , but are often not suitable for uncoupling the radioligand transport parameters (K 1 , k 2 ), which is possible with a single-session MI study. Thus, attempting to compare the in vivo characteristics of FLB457 and fallypride based on the literature findings is difficult because the experiments were not optimized for direct comparison.
The goal of this study was to perform a direct comparison of 18 F-fallypride and 11 C-FLB457 using the MI protocol in the rhesus monkey model. The experiments were designed to obtain estimates of both radioligand transport and binding parameters, with particular interest in the tissue-to-plasma efflux constant (k 2 ) and the in vivo equilibrium dissociation constant (K D ). Knowledge of these radioligand characteristics will aid in the design of future experiments with the goal of maximizing sensitivity to subtle differences in extrastriatal D 2 /D 3 receptor binding and endogenous dopamine competition in applications for studying diseases where disruptions in the dopaminergic system are implicated.
Materials and methods

Chemical Synthesis of 18 F-Fallypride and 11 C-FLB457
The radionuclides were produced with an 11-MeV RDS 112 cyclotron (CTI, Knoxville, TN, USA). For obtaining 11 C-FLB457, 11 C was produced by static irradiation of 10% H 2 /N 2 , producing 11 C-CH 4 in target and converted to 11 C-methyl-triflate using an automated radiochemical system (Larsen et al, 1997) . Labeling of FLB604 precursor and subsequent high-performance liquid chromatography (HPLC) separation were performed according to previously described methods (Lundkvist et al, 1998) . For producing 18 F-fallypride, a modified chemical-processing control unit (CPCU) was used for labeling of the tosyl-fallypride precursor, as previously described (Mukherjee et al, 1995) . After evaporation of the HPLC mobile phase, both 18 F-fallypride and 11 C-FLB457 were dissolved in 0.9% NaCl and passed through a 0.22-mm filter for injection. The precursors and reference standards were purchased from ABX (Radeberg, Germany). Specific activity of the radiotracers was determined using reference standards and analytic HPLC analysis.
For each study, a stock solution of either unlabeled FLB457 or unlabeled fallypride was prepared by dissolving a reference standard in a sterile 10% ethanol/saline solution. For the second and third injections of each experiment, a given volume of the stock solution was thoroughly mixed with the labeled radiotracer, lowering its specific activity as needed per the scan injection protocol.
PET Scans
MI PET data were acquired from two male rhesus monkeys (Macaca mulatta; M1: 7 kg, 6 years; M2: 8 kg, 4 years) using the experimental designs described in Table 1 . The experimental procedures were approved by the University of Wisconsin Institutional Animal Care and Use Committee. For the scanning procedure, the monkeys were initially anesthetized with ketamine (10 mg/kg, intramuscular) and maintained with 0.75% to 1.5% isoflurane for the entire duration of the scan. Atropine was administered intramuscularly at 0.25 mg to minimize secretions. Body temperature, breathing rate, heart rate, and SpO 2 levels were monitored and logged during the course of each scanning session. A catheter was placed in the saphenous vein for the administration of ligand and another was placed in the femoral artery for withdrawing arterial plasma samples.
The PET scans were acquired using a Concorde micro-PET P4 scanner (Tai et al, 2001) , with the animal mounted in a custom head holder in the prone position. After positioning, attenuation scans were acquired for 518 secs using a 57 Co transmission point source. Collection of emission data was initiated with the first bolus injection of radiotracer and continued throughout each of the multiple injections. After the scan, the animals were removed from the scanner bed and from anesthesia. On recovery of the swallowing reflex, the animals were returned to their home cage where they were monitored until they were alert.
Input Function Determination
Arterial blood samples (B0.5 ml each) were drawn throughout the course of each study. The sampling frequency varied from 10 samples/minute after each injection to 0.1 samples/minute after 30 mins. The whole blood samples were mixed with heparinized saline and assayed for radioactivity using a 3 00 NaI(Tl) well counter, cross-calibrated to the PET scanner. Blood samples were then centrifuged at 2200g for 5 mins and 250 mL plasma was extracted. The plasma samples were alkynized with 50 mL sodium bicarbonate before performing two ethyl acetate extractions (500 mL each) to extract the lipophilic species. Both extractions were combined and assayed and converted to radioactivity concentration units after applying a correction for extraction efficiency (B90%). The ethyl acetate was evaporated and thin-layer chromatography was performed to assess the fraction of lipophilic plasma signal arising from lipophilic metabolites.
Whole blood and parent ligand plasma time-activity curves were then parameterized to an analytic function with three exponents to describe the decline of the radiotracer, as given in Figure 1A . Curve stripping was used to generate separate time courses corresponding to each injection subject to a constraint that the slowest component of decline was equal for all injections of each study. The parent ligand plasma time-activity data were converted to units of molar concentration (pmol/mL) through division by the injected specific activity. A decay correction was applied to the molar concentration to represent the 'cold' ligand, which does not undergo radioactive decay.
Image Processing
The PET list mode data were binned into sinograms with durations of 30 seconds per frame, with corrections applied for scanner deadtime and random coincidence events. Emission sinograms were reconstructed with filtered backprojection using a 0.5 cm À1 ramp filter, zoom of 1.5, and 128 Â 128 Â 63 voxel matrix size with a voxel size of 1.26 mm Â 1.26 mm Â 1.21 mm, with corrections applied for attenuation, scanner normalization, and scatter to create images with quantitative units. The data were not decay-corrected, as radioactive decay is accounted for in the model. The reconstructed time series for each monkey were spatially transformed into a common space for generation The measured input function radioactivity from the M1a fallypride study (circles) and the fit of measured data, as fit with three separate input functions (dotted lines) and the sum of the three input functions (solid line). The horizontal bar indicates the time period where no blood samples were drawn due to an obstructed arterial draw line. (D) Three input functions scaled by specific activity, shown in pmol/cc (M1a fallypride). (E, F) Same as in panels C and D, but for FLB457 (M1c).
of regional time-activity curves. A rigid-body registration was performed to the integrated images of 11 C-FLB457 and 18 F-fallypride using the FSL flirt software, and the affine transformation was applied to the entire dynamic PET series (Smith et al, 2004) . Regions of interest (ROIs) were centrally placed within the boundaries of each region on the integrated PET image and applied to the dynamic time series for each study. Time-activity curves were obtained for the general regions of the thalamus, substantia nigra (SN), temporal cortex, prefrontal cortex, caudate, and cerebellum. The ROI placement for each region is shown in Figure 2 . The thalamus region (0.13 cm 3 ) was placed predominantly over the medial dorsal portion of the thalamus; the SN (0.14 cm 3 ) over the pars compacta and other SN sub-regions unidentifiable in PET images; the temporal cortex region (TmpCtx) (0.87 cm 3 ) represented the superior temporal sulcus; and the frontal cortex region (1.26 cm 3 ) encompassed the dorsal prefrontal cortex (PFC). The caudate time-activity data were also incorporated into the parameter estimation process (although not for estimation of receptor density). The caudate (caud) region was defined over the central area of the caudate head using a volume of 0.16 cm 3 . No distinction was made between left and right regions. The cerebellum ROI (cbm) (0.63 cm 3 ) was drawn over the cortex of the cerebellar lobes and positioned to avoid signal from the white matter, vermis, and surrounding regions.
Optimization of Experimental Design
A single-session, MI design using the labeled-unlabeled model describes the in vivo kinetics of the ligands (Delforge et al, 1990) . The MI experiments were designed with the goal of yielding optimal parameter identifiability for the PET model parameters describing plasma-tissue transport [K 1 , k 2 ] and ligand-receptor binding [f ND k on , k off, B max ] (Innis et al, 2007) , with special focus on regions of low binding, such as the cortex. The protocol design involved a multiple-step optimization procedure, first using sensitivity analysis and then Monte Carlo (MC) methods. Initial designs investigated protocols with three serial injections of radiolabeled and unlabeled ligand. The entire experimental design was constrained to be less than 3 hours.
Sensitivity analysis was performed to determine the injection protocol that maximizes the determinant of the reduced hessian matrix (H R ) based on the preliminary parameter estimates reported for 18 F-fallypride and 76 Br-FLB457 (Delforge et al, 1999) , using arterial plasma input functions obtained from preliminary studies. Only binding parameters (f ND k on , B max , k off ) were included in H R . The parameters for the optimization algorithms included injection times for the second and third injections as well as the radioactivity and mass injected for each of the three injections. The optimization was performed to select the protocols that yielded the highest parameter precision in the H R .
MC simulations were then performed to assess the effects of noise on parameter precision and to examine the sensitivity for estimation of K 1 and k 2 , which were not included in H R during the initial sensitivity analysis. These simulations were performed by simulating 100 instances of MI PET curves, adding noise to the simulated data, ROI model , using a noise model similar to a previously published method (Logan et al, 2001) :
Subscripts '*' and 'model' represent simulated noise-added and pre-noise (simulated) data, and G(0,1) represents a normally distributed random number with mean 0 and standard deviation 1. Constants c 1 (0.5 to 2.5) and c 2 (0 to 75) represent noise levels, each adjusted to mimic the noise level of the ROI being simulated. The noisy simulated data (ROI * (t)) were fit using methods as described below. The protocol with fits giving the most accurate and precise estimation of the input parameters was used for the PET scanning sessions. Both sensitivity analysis and MC simulations were repeated before each PET scanning session, using refined starting estimates based on measured data from earlier studies. After the initial 18 F-fallypride study (M1a), the optimization protocol was revised, leading to the second 18 F-fallypride study (M2a) using a protocol with only two injections. After the first 11 C-FLB457 study (M1b), the transport (K 1 , k 2 ) and k off estimates were updated for the sensitivity analysis procedures. The sensitivity analysis results suggested multiple protocols that were further examined using the MC methods, leading to selection of a new protocol for M2 (M2b) with an increase in the time between injections. After acquisition of the second 11 C-FLB457 study, the protocol was revised in the same manner leading to another protocol for a third 11 C-FLB457 experiment (M1c), which was slightly adjusted to match the timing in M1a. The experimental protocols used for the multiple-injection (MI) studies are given in Table 1 .
Multiple Injection (MI) Model
Model Description: For MI experiments with three injections (i = 1, 2, 3), there are a total of three differential equations describing the rate of change of the free ligand concentration (dF/dt) and another three differential equations describing bound (dB/dt) ligand concentration, which are as below:
These six differential equations share the same values for the plasma-to-tissue rate constant (K 1 ), tissue-to-plasma efflux constant (k 2 ), the ligand-receptor association (f ND k on ), dissociation (k off ) rate constants, and receptor density (B max ). The molar concentration of the ligand in the arterial plasma (C pi ) for each injection serves as the input function to the model. The output signal measured by the PET scanner (Model j ) is related to the state variables by the equation:
( ) dt with j dynamic PET frames and specific activity injection of SA i for each injection, and t begin and t end the beginning and ending times of each frame, respectively. The bloodborne component in each region is modeled as the whole blood time course (C WB (t)) multiplied by the fractional blood volume (F V ), which was set at F V = 0.04.
Parameter Estimation: The following assumptions were used in an effort to increase parameter identifiability in these regions of the brain with varying levels of dopamine D 2 /D 3 receptors:
(i) Both 18 F-fallypride and 11 C-FLB457 were assumed to bind to the same set of D 2 /D 3 receptors in the brain. Thus, receptor density B max was constrained to a single value for both radiotracers. (ii) The in vivo association (k on ) and dissociation (k off ) rate constants, and the non-displaceable (ND) free fraction (f ND ) are uniform across the examined brain regions for both radiotracers.
Model configuration and parameter estimation were performed using the COMKAT software algorithms (Muzic and Cornelius, 2001) . A constrained non-linear search using the Levenberg-Marquardt optimization algorithm was performed for estimation of the kinetic parameters.
The parameter estimates were made both on an individual ROI basis and simultaneously in multiple regions using an objective function that minimized the total sum of squares residual, RSS, across N ROIs consisting of J frames each, as given below.
Depending on what parameters we were trying to estimate, a subset of the p was used, where p ¼ ½f ND k on ; k off ; ½K 1n ; K 2n ; B maxn n . Uniform weighting (w n,j = 1) was used for all of the frames (which were of equal duration) (Muzic and Christian, 2006) . All rate constants (K 1 , k 2 , f ND k on , k off ) were constrained to fall within the bounds of [0,1] (min À1 , ml cm À3 min À1 ). B max was constrained to [0,100] (nmol L À1 ). Estimation of the individual rate constants was performed in a stepwise manner, incorporating the assumptions outlined above, following these three steps:
Step 1. Determination of k off : The identifiability of k off is greatest in the regions of the brain with high specific receptor binding, particularly during the period of radioligand displacement. The PET time series from the caudate, thalamus, and SN were used to obtain the estimate of k off , using the parameter set p ¼ ½f ND k on ; k off ; ½K 1n ; K 2n ; B maxn n and n = 1,2,3 for these regions. It should be noted that in the caudate, only k off could be sufficiently uncoupled from the other parameters and this region was not used for estimation of the other parameters. These methods provided a single k off value for each individual study (and radiotracer).
Step 2. Determination of regional B max : The PET time series from the thalamus, SN, PFC, and TmpCtx were then used for estimation of the parameter set p ¼ ½f ND k on ; ½K 1n ; K 2n ; B maxn n , using a fixed value for k off as determined from Step 1. Thus f ND k on was constrained to be uniform across all brain regions, whereas regional differences were accounted for by differing receptor density and plasma transport rates. A mean B max was then obtained for each brain region based on an average of the data obtained from the 18 F-fallypride and the 11 C-FLB457 studies.
Step 3. Determination of f ND k on and regional K 1 , k 2 : Using fixed values for k off and B max , the PET time series was then used for the final estimation of
The apparent equilibrium dissociation constant was then calculated for each radiotracer in each monkey as follows:
Fitting Cerebellum Data: In the cerebellum, the rate constants were determined using both a one-compartment model (1CM) and a two-compartment model (2CM). For 1CM fitting, we used p = [K 1 , k 2 ] and for 2CM fitting we used p = [K 1 , k 2 , B max ], with f ND k on and k off fixed to values determined using the methods described above from the other brain regions. The Akaike Information Criterion (Akaike, 1974) was calculated for comparing the models to examine whether the presence of the additional term for receptor density (B max ) in the 2CM model was justified.
Estimation of Uncertainty
Uncertainty in parameter estimates was performed using MC methods similar to those described by Salinas et al (2007) . Noise-free data were first simulated on the basis of the implemented experimental protocols and final parameter estimates. Noise was then added in a manner identical as described in the optimization section. A total of 65 trials were run for each radiotracer (five ROIs each). Multi-step fitting procedures were used as described above. The standard deviation (s.d.) and mean of the parameter estimates across trials were calculated to give a coefficient of variation (COV = s.d./mean).
Results
Input Function Determination
The results of the input function fitting procedure for the M1 18 F-fallypride study are shown in Figures  1C-1F . Figure 1B shows a comparison of the arterial plasma time-activity curves of parent radioligand for 11 C-FLB457 and 18 F-fallypride. The data are normalized to the injected dose and shown for the first 40 mins after injection and averaged over the three injections. These plots show that native 11 C-FLB457 was cleared from the arterial plasma faster than native 18 F-fallypride. The fraction of parent compound was 2 to 4 times higher for 18 F-fallypride than for 11 C-FLB457 at approximately 5 mins after injection. The faster rate of clearance of 11 C-FLB457 continued throughout the course of the study, with the slowest exponential component of 0.033 min À1 for 11 C-FLB457 and 0.017 min À1 for 18 F-fallypride, on average.
Optimization of Experimental Design
Using MC methods, it was found that the identifiability of K 1 and k 2 was not affected by the experimental design within the range of schemes required for f ND k on , k off , and B max identifiability. For 18 Ffallypride, the parameter identifiability could be achieved with only two injections, thus the saturating dose (injection-3) was eliminated from the fallypride protocol for M2. For 11 C-FLB457, the initial parameter estimates used for optimization led to a protocol with injection times at 0, 30, and 60 mins (see Table 1 ). This preliminary study did not adequately identify B max and f ND k on , yielding a correlation between parameter estimates greater than 0.9. To better identify f ND k on and B max , this protocol was then refined by increasing the time interval between the injections for the second and third 11 C-FLB457 experiments.
Parameter Estimates
Of the specific binding parameters f ND k on , B max , and k off ; identifiability was greatest for k off , showing a small covariance with the other parameters. k off was found to be slower for 11 C-FLB457 than for 18 F-fallypride, with an average value of 0.016 min À1 and 0.022 min À1 , respectively ( Table 2) . As indicated in the methods, the estimate of k off was best for M1b due to the long period of scanning after the third injection, but other parameters were most identifiable from the M1c study. Accordingly, the M1 11 C-FLB457 results presented in Table 2 represent an average of data from M1b and M1c.
All of the experiments for 11 C-FLB457 and 18 Ffallypride showed high identifiably for both transport parameters and ligand-receptor interaction parameters, with the exception of f ND k on for 11 C-FLB457 for M2. For this study, a range of estimates for f ND k on and k off are reported that provided similarly acceptable fits to the data, with the average values reported in Table 2 . Within this range estimates for f ND k on and k off , K 1 and k 2 were largely unaffected, due to the small covariance between the parameters of transport and binding. When averaged across both monkeys, K Dapp for 18 F-fallypride is found to be higher than that of 11 C-FLB457 (0.39 nmol/L versus 0.13 nmol/L). Figure 3A shows an example of the measured PET data and the model fit to the data.
The precision of the parameter estimates is given as COV, as derived by MC-based methods. For 11 C-FLB457 fits, the most precise COVs were for K 1 and k 2 estimates (2%), followed by B max (6%), k off (9%), and f ND k on (12%). The error associated with 18 Ffallypride estimates gave COVs of 4% for K 1 and k 2 , 5% for B max , and 3% for f ND k on and k off .
Cerebellar Kinetics
The parameter estimates for cerebellar data are shown in the bottom of Table 2 . An example of the data fit for M1 is shown in Figure 3B , comparing both 2CM and 1CM models. For both 11 C-FLB457 studies, the 2CM model provided the most appropriate fit using the Akaike information criterion, which is visually evident in Figure 3B . For 18 F-fallypride, the 1CM model was adequate for describing the data. It was also found that 11 C-FLB457 showed considerably higher ND volume of distribution, V ND ( = K 1 /k 2 ), than 18 F-fallypride; primarily attributable to the lower k 2 of 11 C-FLB457. This difference in V ND holds for both 1CM and 2CM models.
Discussion
The motivation for this study was to perform a direct comparison of the kinetics of two commonly used PET radioligands for assaying extrastriatal D 2 /D 3 binding, 18 F-fallypride and 11 C-FLB457. Although a single-bolus-injection experimental design is most feasible for studying changes in receptor-ligand binding (through DVR or BP ND ) in humans, such a design cannot uncouple the individual transport and binding processes of the radiotracer. We have chosen to implement this experimentally complex protocol to directly compare and characterize the in vivo rate constants of 11 C-FLB457 and 18 F-fallypride to guide experimental design for future studies and to evaluate the strengths and weaknesses of each radiotracer for extrastriatal D 2 /D 3 assessment.
Plasma Analysis
Measurements show that 11 C-FLB457 is removed from the blood much more quickly than 18 F-fallypride. Rapid metabolism and clearance of radioligand from the plasma could be advantageous as it permits a shorter scanning duration to achieve a stable measure of receptor binding. However, the accuracy of the measured arterial concentration is greatly diminished due to low counting statistics due to the short half-life of the 11 C radiolabel.
The rapid metabolism for both tracers resulted in hydrophilic species, which did not cross the bloodbrain barrier. At later time points the lipophilic metabolites were present in the ethyl acetate extraction along with the parent compound as assayed by thin-layer chromatography. The fraction of non-parent lipophilic species did not exceed 20% for either radiotracer at the time prior to subsequent injection. However, the uncertainty in this measurement was high, particularly for 11 C-FLB457, and corrections for the presence of these radiolabeled species were not applied to the input functions. Previous analysis of MI experiments has shown that with MI protocols involving multiple injections of radioligand, the presence of the lipophilic fraction had a negligible effect on the parameter estimates because the relative proportion remained small with the addition of parent compound at each injection . These effects of lipophilic metabolites on the parameter estimates were further examined for both 18 F-fallypride and 11 C-FLB457 through simulations of various levels of lipophilic metabolites. As a greater fraction of lipophilic plasma concentration was attributed to lipophilic metabolites a The values reported for M2 FLB are averages of estimates in a range k on = 0.1 to 0.2, k off = 0.010 to 0.025, and K Dapp = 0.1 to 0.2. b K Dapp = k off /f ND k on . This is a calculated value based on f ND k on and k off , and was not a parameter included in the fit to the data. c V ND = K 1 /k 2 for 2CM. This is a calculated value based on K 1 and k 2 , and was not a parameter included in the fit to the data. d V T = V ND = K 1 /k 2 for 1CM. This is a calculated value based on K 1 and k 2 , and was not a parameter included in the fit to the data.
(up to the extreme case of a 50% lipophilic metabolites at 100 mins), the associated change in kinetic parameter estimates was only significant in f ND k on and resulted in an approximately 10% reduction in this parameter.
Optimization of Experimental Design
MI experiments must be properly designed for the injection timing and the proportion of radiolabeled and unlabeled compound to yield estimated parameters that are uniquely identified. However, MI optimization procedures present a challenge because the procedures used require a priori information about the transport and binding characteristics of a tracer when the goal of the experiments is to determine these very parameters. On the basis of our previous experience with 18 F-fallypride , it was possible to achieve excellent identification of all the parameters with 18 F-fallypride in both animals. The results of the first 18 F-fallypride study (M1a) led to elimination of the third injection for the second study (M2a) on the basis of a robust design-optimization strategy described by Salinas et al (2007) . Finding a protocol giving good parameter estimation for 11 C-FLB457 was not so straightforward. We acquired two scans (M1b, M2b) with poor identifiability for f ND k on and B max before finding a protocol that was able to sufficiently identify these parameters of binding (M1c). This was achieved by increasing the interval between the injections to provide additional data, which were needed to adequately uncouple the delivery and rapidly binding processes.
Model Assumptions
Several constraints were enforced to increase the identifiability of the estimated in vivo rate constants (by minimizing the total number of simultaneously estimated parameters). For 11 C-FLB457 and 18 F-fallypride, the ligand-receptor association (k on ) and dissociation (k off ), and the ligand-free fraction (f ND ) were assumed to be uniform across all regions of the brain for each individual. This assumption of a uniform apparent K D across brain regions also implies that synaptic dopamine concentration is uniform across regions. The estimation of k off can be made with high precision (B3%) in the brain regions where the PET signal is dominated by the specifically bound compartment, which is visually evidenced by displacement of radioligand after saturating doses of ligand. This was the motivation for including the region of the caudate for the estimation of k off only. To further validate the use of a uniform k off , each of the regions (caudate, thalamus, SN) were first fit independently for k off and the resulting estimates were all within 30% of the shared value. Consistent estimates of k off across mediumand high-density D 2 /D 3 regions have also been previously reported for these radiotracers (Delforge et al, 1999 ). In the low-receptordensity regions, the use of a fixed k off serves to minimize the coupling with the transport and forward binding constants.
The assumption of uniform f ND across regions is commonly assumed in all PET methods of analysis using a reference region to account for the ND compartment (e.g., BP P and BP ND ) (Innis et al, 2007) . As a result, the constraints of f ND k on and k off across all regions of the brain will yield a uniform apparent K D for each radioligand. The concentration of receptor sites available for binding (B max ) was also constrained to be equal for 11 C-FLB457 and 18 F-fallypride. To accommodate this assumption, both radiotracers must not only have high selectivity for the D 2 /D 3 receptors, but also possess a similar ratio of D 2 and D 3 affinities. In vitro comparisons of D2 long and D3 affinities have been reported for fallypride (Ki D2long :Ki D3 = 2.2 nmol/L: 1.6 nmol/L) and FLB457 (Ki D2long :Ki D3 = 0.65 nmol/L: 0.42 nmol/L) using 3 H-spiperone, thus showing a consistent relation for both ligands (Stark et al, 2007) . Some discrepancy was reported when comparing the D2 short and D2 long isoform affinities between fallypride (Ki D2long :Ki D2short = 2.2 nmol/L:2.1 nmol/L) and FLB457 (Ki D2long :Ki D2short = 0.65 nmol/L:1.6 nmol/L). In our data, there was no apparent bias for the estimation in the region of the SN, believed to consist predominantly of D2 short receptors (Kahn et al, 1998) , by assuming an identical B max for 11 C-FLB457 and 18 Ffallypride binding, and the constraint was applied to be consistent with the other brain regions. Accordingly, the constrained values for B max were similar to the values as derived independently (i.e. M1 SN B max : fallypride = 2.8 nmol/L, FLB457 = 3.3 nmol/L, average = 3.0 nmol/L).
Regional Binding and Transport
Examination of the results show that the main differences between radiotracers lie in their affinity for D 2 /D 3 receptors and the rate at which they clear out of tissue from the free space. Using the averages of both studies, we report an apparent K D (in vivo, K Dapp = k off /f ND k on ) of 0.39 nmol/L for 18 F-fallypride and 0.13 nmol/L for 11 C-FLB457. This three-fold difference can be attributed to the combination of faster binding and slower dissociation of 11 C-FLB457 as compared with that of 18 F-fallypride. This difference is relatively consistent, with a twofold difference in humans (Narendran et al, 2009 ) and in vitro measures of K D (0.030 nmol/L versus 0.018 nmol/L) (Halldin et al, 1995; Mukherjee et al, 1995) and K i (2.2 nmol/L versus 0.65 nmol/L, using 3 H-spiperone) for fallypride and FLB457, respectively. For fallypride, the measured apparent dissociation constant is in close agreement with 0.38 nmol/L from previous studies using the rhesus monkey , but lower than 1.3 nmol/L as reported for the baboon (Slifstein et al, 2004a) . For FLB457, the literature values have been reported as 0.21 nmol/L for the baboon (Delforge et al, 1999) and 0.35 nmol/L and 0.9 nmol/L for humans (Olsson et al, 2004; Suhara et al, 1999) .
The delivery of the parent compound from the plasma to the free space of the tissue (K 1 ) was similar for both radiotracers, yielding a mean of K 1 = 0.48 ± 0.15 mL/cm 3 /min for 18 F-fallypride and K 1 = 0.54 ± 0.10 mL/cm 3 /min for 11 C-FLB457 when averaged across all brain regions. However, there was a large difference in the tissue-to-plasma efflux constant, k 2 , with values of 0.54 ± 0.10 min À1 for 18 F-fallypride and 0.18±0.05 min À1 for 11 C-FLB457. On the basis of these findings, it is seen that the ND distribution volume (V ND = K 1 /k 2 ) is more than three-fold larger for 11 C-FLB457 than 18 F-fallypride: 3.0 mL/cm 3 as compared with 0.9 mL/cm 3 . This measure of V ND for 18 Ffallypride is consistent with our previous findings using the rhesus monkey through the MI approach . For 76 Br-FLB457, previous MI experiments reported a V ND of 0.35 mL/cm 3 for the baboon (Delforge et al, 1999) . Recent studies of humans found a V ND of 2.9 mL/cm 3 for 11 C-FLB457 (Asselin et al, 2007) , which is in closer agreement with the value reported here. This large discrepancy in V ND for FLB457 may be species or methodology dependent; however, it does emphasize the importance of performing radioligand comparisons on the same subjects.
The significant difference in V ND between 11 C-FLB457 and 18 F-fallypride may, in part, be due to the higher lipophilicity of fallypride. Generally, higher lipophilicity produces a reduction in the free compound in both the plasma (f p ) and brain tissue (f ND ), and V ND depends on the ratio of these fractions at equilibrium. On the basis of literature values using HPLC measurement, 18 F-fallypride has a log k w = 2.43 (Mukherjee et al, 1995) and 11 C-FLB457 has a log k w = 1.89 (Schmidt et al, 1994) . In silico measurements support the higher lipophilicity of fallypride, with an average log P-value of 3.3 for fallypride and 2.9 for FLB457, as calculated using ALOGPS (Tetko and Yu, 2005) .
Effect of k 2 Differences
One of the primary differences in the in vivo behavior of 11 C-FLB457 and 18 F-fallypride is the tissue-to-plasma efflux constant (k 2 ). For 11 C-FLB457, the approximately threefold reduction in k 2 results in a significantly higher signal in the ND compartment, frequently measured in the cerebellum. Such an increase in this component of the PET signal is advantageous for radiotracers that require an extended PET scanning duration to achieve BP ND stability by improving the statistics in the PET signal. On the basis of the examination of M1 in this study, it was found that at 80 mins after injection, the decaycorrected 11 C-FLB457 study yielded a cerebellar concentration that was 70% greater than that in the 18 F-fallypride study, despite having a plasma concentration that was 85% less than that of 18 Ffallypride. This increased signal in the ND compartment also improves visualization of the cortical regions, which can aid in the definition of ROIs or in spatial co-registration or normalization. However, as the signal-to-noise ratio is dependent on measured counts (and not decay corrected counts), this advantage of increased V ND is lost for 11 C-FLB457 as compared with 18 F-fallypride, due to its shorter halflife of the radiolabel.
The k 2 parameter also plays a role in the sensitivity of a radioligand for measuring changes in endogenous dopamine competition. Through use of computer simulations, Morris and co-workers performed a detailed comparison of prospective radioligands available for measuring dopamine transmission in the brain (Morris and Yoder, 2006) . In their survey of these radiotracers, it was found that fallypride was almost three-fold more sensitive than FLB457 to dopamine displacement. In the case of dopamine displacement, the radioligand is administered prior to a manipulation (i.e. administration of amphetamine), which induces the release of endogenous dopamine, and in turn displaces the radiotracer from the specifically bound receptors. For displacement experimental designs, the PET detection sensitivity of a radioligand will be enhanced by rapid dissociation (k off ) and tissue clearance (k 2 ), thus enhancing the contrast in the PET signal before and after dopamine release. For dopamine displacement experiments, the faster kinetics of fallypride will improve detection sensitivity, but only in regions where sufficiently high PET signal is present. A recent study by Narendran et al (2009) directly compared 11 C-fallypride-and 11 C-FLB457-measured BP ND changes before and after endogenous dopamine competition in humans using an amphetamine challenge. Their results found that 11 C-FLB457 showed 30% to 70% higher sensitivity (through DBP ND ) to dopamine competition than 11 C-fallypride in the cortical regions of the brain. In contrast to the 'displacement'-type study, this 'blocking'-type study is designed to have the competing dopamine present prior to the administration of the radioligand. This difference in study design favors 11 C-FLB457 for the blocking-type experiment, because this design is less sensitive to the combination of slow binding dissociation, increased PET signal in both the specifically bound and ND states, and the higher proportion in the specifically bound state relative to the ND state.
Cerebellar Kinetics
The radiotracer kinetics in the cerebellum are of great importance for PET D 2 /D 3 receptor studies because it is commonly used as a reference region in BP ND determination. In this study, it was found that significant specific binding could be measured in the cerebellum for 11 C-FLB457 but not for 18 F-fallypride.
The presence of specific D 2 /D 3 binding in cerebellum has been frequently reported in the literature for 11 C-FLB457 (Asselin et al, 2007; Delforge et al, 1999; Olsson et al, 2004) , leaving one to conclude that similar issues with specific cerebellar binding would be present with 18 F-fallypride. The inability of fallypride to detect specific cerebellar binding in this study can be explained, in part, by its lower in vivo affinity when compared with FLB457. A B3 Â higher apparent K D of fallypride will result in a 3 Â lower bound-to-ND fraction at equilibrium. However, the insensitivity to cerebellar binding is also attributed to several other characteristics of fallypride, including the reduced radiotracer clearance from the blood, faster k 2 , and slower rate of receptor-ligand association (f ND k on ) as compared with FLB457.
To investigate the sensitivity of both tracers to a small level of cerebellar binding, we compared simulations of the cerebellum-to-plasma ratios for both radiotracers assuming a receptor density of 0.1 nmol/L, as shown in Figure 4 . In the absence of specific binding, this ratio should plateau at V ND . In the presence of specific binding, the ratio will plateau at V T ( = V ND + V S ) (as simulated in Figure 4 ). The distinctive upward bend in the 11 C-FLB457 curve is due to the fast f ND k on combined with the rapidly declining plasma concentration. It can be seen that this shape in the curve is enhanced by the slower k 2 and k off of 11 C-FLB457. Thus, the slow clearance of 11 C-FLB457 from the tissue acts as a leaky integrator of the radiotracer, enhancing the opportunity for the ligand to specifically bind to the receptor sites. This shape is not seen with 18 F-fallypride because of the combination of slower plasma clearance of the parent ligand, a slower rate of specific binding, and faster dissociation from specific binding sites.
When using a reference region method of analysis, such as the Logan DVR graphical method, specific cerebellar binding will result in an underestimation of BP ND , with the following relationship between measured BP ND and true BP ND being derived:
The effect of specific binding in the cerebellum on the measurement of BP ND is shown in Figure 5 , where the higher degree of underestimation for FLB457 can be attributed to its higher affinity. Of primary importance is the non-linearity in bias in the low-density regions where the receptor density is only slightly greater than that found in the cerebellar lobes. Across a cohort of animals with variable levels of cerebellar binding, this will result in high variability of BP ND estimation in low-receptordensity regions such as the cortex. We have recently reported high variability in cortical 18 F-fallypride binding (in BP ND ) in a large cohort of rhesus monkeys (Christian et al, 2009) , which may be a direct consequence of cohort variation in cerebellar D 2 /D 3 receptor concentration. The extent and variability of D 2 /D 3 density in the cerebellum (lobes) in the population is not known, and thus it is not possible to assess the variability in BP ND due to cerebellar specific binding. Without knowledge of specific cerebellar binding, caution must be used in interpreting binding in low-density regions when reference region methods are employed.
Conclusions
There is a high degree of similarity in the visual appearance of the PET images of 18 F-fallypride and 11 C-FLB457, with both radiotracers yielding similar target-to-background ratios throughout the brain regions, with differing D 2 /D 3 receptor densities. However, assessing the performance of a radiotracer simply on the basis of target-to-background ratios can lead to a misguided understanding of a radiotracer's ability to provide an accurate measure of receptorligand binding (Eckelman et al, 2009 ). Compared with fallypride, FLB457 shows faster ligand-receptor binding and slower dissociation from the receptor, translating into an equilibrium dissociation constant that is approximately three times lower. Fallypride clears from the ND space faster and remains in the plasma longer than FLB457. The higher affinity and ND component of FLB457 will provide higher tracer uptake in the cortical and cerebellar regions; however, this will be offset by lower counting statistics when using a 11 C radiolabel. These properties suggest that 18 F-fallypride is better suited for endogenous displacement-type experiments. For reference region methods of analysis, both radiotracers will suffer from potential BP ND bias in the low binding regions. Figure 4 Cerebellum-to-parent plasma ratios assuming a cerebellar D 2 /D 3 receptor concentration of 0.1 nmol/L. (A) Simulated cerebellum/plasma curves using FLB457 measured plasma input function; (B) curves generated using measured 18 F-fallypride plasma concentration. Both fallypride-like kinetics and FLB457-like kinetics are represented using each plasma input function. Variations in k on from the tracer's true k on value ( ± 50%) are shown by dotted and dashed lines. The thick solid lines indicate the kinetics parameters of FLB457, with a FLB457 input function (A) and fallypride kinetic parameters and fallypride input (B). The presence of cerebellar binding may preclude the use of reference region methods for cortical D 2 /D 3 assay.
